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Abstract
Salmonella enterica is a common cause of diarrhea. For eliciting disease, the pathogen has to colonize the gut lumen, a site
colonized by the microbiota. This process/initial stage is incompletely understood. Recent work established that one
particular strain, Salmonella enterica subspecies 1 serovar Typhimurium strain SL1344, employs the hyb H2-hydrogenase for
consuming microbiota-derived H2 to support gut luminal pathogen growth: Protons from the H2-splitting reaction
contribute to the proton gradient across the outer bacterial membrane which can be harvested for ATP production or for
import of carbon sources. However, it remained unclear, if other Salmonella strains would use the same strategy. In
particular, earlier work had left unanswered if strain ATCC14028 might use H2 for growth at systemic sites. To clarify the role
of the hydrogenases, it seems important to establish if H2 is used at systemic sites or in the gut and if Salmonella strains may
differ with respect to the host sites where they require H2 in vivo. In order to resolve this, we constructed a strain lacking all
three H2-hydrogenases of ATCC14028 (14028
hyd3) and performed competitive infection experiments. Upon intragastric
inoculation, 14028hyd3 was present at 100-fold lower numbers than 14028WT in the stool and at systemic sites. In contrast,
i.v. inoculation led to equivalent systemic loads of 14028hyd3 and the wild type strain. However, the pathogen population
spreading to the gut lumen featured again up to 100-fold attenuation of 14028hyd3. Therefore, ATCC14028 requires H2-
hydrogenases for growth in the gut lumen and not at systemic sites. This extends previous work on ATCC14028 and
supports the notion that H2-utilization might be a general feature of S. Typhimurium gut colonization.
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Introduction
The gut lumen is colonized by a dense microbial community
called the microbiota. The microbiota performs numerous
important functions which have been the topic of intense recent
research (reviewed in [1]). One prominent function is the
consumption of complex carbohydrates which the host is not able
to digest. This is facilitated by primary fermenters which break
down dietary and mucus-derived polymers and ferment the
monomers into short chain fatty acids, lactate, CO2, formate and
H2 [2]. These primary fermentation products are subsequently
absorbed by the host, consumed by secondary fermenters or
released into the atmosphere. Importantly, the metabolic activity
of the microbiota limits gut luminal nutrient availability for
incoming bacteria and thereby helps to prevent infection
(‘‘colonization resistance’’; [2–4]). Enteric pathogens must have
the ability to overcome colonization resistance in order to cause
infection. However, these strategies are still not well understood.
Salmonella enterica is a Gram-negative bacterial species eliciting
enteric infections in a wide range of hosts [5,6]. In warm-blooded
animals, most infections are caused by S. enterica subspecies 1, e.g.
serovar Typhimurium. Using the S. Typhimurium strain SL1344,
we have recently begun to investigate how the pathogen can
establish in the host’s gut in the face of an intact microbial
community [7–9]. In this initial phase of colonization, the mucosa
does not yet show any overt symptoms of disease and microbiota
metabolism is thought to function normally. Here, SL1344 was
found to capitalize on molecular hydrogen (H2), a central product
of microbiota metabolism [8]. Specifically, H2 serves as an
electron donor consumed by H2-hydrogenases, i.e. the hyb-
hydrogenase. This is a well-characterized cytoplasmic membrane
enzyme complex which abstracts the electrons from H2 and
channels them into the ubiquinone pool [10–17]. During SL1344
growth in the mouse gut, about 90% of these electrons are
transferred to fumarate, a step catalyzed by the fumarate reductase
(frd; [8]). Overall, this anaerobic H2-consumption fuels SL1344
growth to such an extent that hydrogenase mutants are 100-fold
attenuated in competitive gut colonization assays. This is true for
the hyb mutant of SL1344 and for a SL1344 mutants lacking all
three H2-hydrogenases. However, it had remained unclear, if this
also holds for other Salmonella strains.
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In many cases, mechanisms discovered in one strain are equally
relevant for other strains of the serovar Typhimurium and often
even for the entire S. enterica species. However, there is
accumulating evidence that this is not always the case. Strain-
specific differences in virulence, growth or other phenotypes can
arise from sequence variations or differences in gene content (see
below). While, S. enterica strains can differ by as much as 65 to
99% of their genetic content [18–22], many strains from the
serovar Typhimurium are much more similar to each other
[23,24]. The S. Typhimurium strain ATCC14028 employed in
this study differs from strain SL1344 by just 2.6% of its genome
[24,25]. These differences comprise the prohage SopEW (present
in SL1344 [26,27], not ATCC14028), the prophage Gifsy-3
(present in ATCC14028, not SL1344; [28]), different plasmid
contents, a histidine auxotrophy (in SL1344, not ATCC14028)
[29], as well as numerous sequence polymorphisms distributed
throughout the genomes (e.g. one TRC change in a H2-
hydrogenase operon, resulting in an R188RG188 amino acid
exchange in HyaB2). In many cases (including the H2-hydroge-
nase operons), the functional consequences of the presence, the
absence or the mutation of a particular gene have remained
unclear. SopEW is a notable exception. This prophage encodes a
gene cassette (‘‘moron’’) in its tail-fiber region which encodes SopE
[30–32], a RhoGTPase activating effector protein which is
injected into host cells via the SPI-1 type III secretion system
[33,34]. SopE dramatically enhances the capacity of S. Typhi-
murium strains to trigger membrane ruffling and elicit mucosal
infection in cows and mice [33–36] Moreover, the absence of
SopE (or SopEW) was found to explain why ATCC14028 (but not
SL1344) utilizes the terminal electron acceptor tetrathionate for
anaerobic respiration in the lumen of the inflamed gut [37]. This
was of particular interest, as both strains encode for the genes
required for anaerobic tetrathionate utilization. Thus, genetic
comparison alone seems insufficient to predict the utilization of
metabolic pathways in vivo, as genetic differences in unrelated
genes (e.g. the virulence factor SopE) can substantially affect
metabolic preferences in complex environments such as the mouse
intestine. Therefore, experimental verification is indispensable to
address the question whether a particular anaerobic pathway is
used by a given Salmonella strain.
Indeed, earlier work on S. Typhimurium strain ATCC14028
suggested that differences in H2 metabolism might exist [14]. H2-
hydrogenase mutants of this strain were found to be strongly
attenuated at colonizing systemic sites. This was taken as evidence
that ATCC14028 uses H2 to fuel growth, but it had remained
unclear if this was attributable to H2-dependent growth in these
organs or in the intestinal tract. In fact, this H2-fuelled growth of
ATCC14028 at systemic sites seemed plausible, as microbiota-
derived H2 is well known to diffuse even to distant sites in the body
(an average of 40 mM of microbiota-derived H2 are found in the
mouse liver/spleen [14]) and significant amounts of H2 are
exhaled via the lungs [38,39]. This left us with the possibility that
different S. Typhimurium strains may use microbiota-derived H2
at different sites i.e. the gut lumen (strain SL1344) or at systemic
organs (strain ATCC14028). However, it could not be excluded,
that this was simply attributable to slight differences in the
experimental design and the subsequent interpretation of the data.
It is important to note that the ATCC14028 experiments had been
performed in the typhoid fever model of Salmonella infection
[14,40]. In this type of experiment, the mice are inoculated via the
oral route and the pathogen traverses the intestinal mucosa before
disseminating to systemic sites. This left room for an alternative
interpretation of the ATCC14028 data: the systemic colonization
defect of ATCC14028 hydrogenase mutants might be attributable
to a brief phase of gut luminal pathogen growth. A gut luminal
growth defect of the ATCC14028 hydrogenase mutant could have
skewed the ratio of wild type vs mutant bacteria before systemic
colonization was initiated. However, gut luminal growth had not
been monitored in the previous study, and it remained unresolved
if H2-fuelled growth in the gut lumen may have contributed to the
phenotype. Therefore, it remained to be established whether
ATCC14028 uses microbiota-derived H2 for colonizing the gut
lumen, or for growth at systemic sites.
Results and Discussion
H2-hydrogenases are required for efficient gut
colonization by ATCC14028
ATCC14028 is known to encode three H2-hydrogenases which
are largely identical to the operons in SL1344. In order to generate
an isogenic H2-hydrogenase deficient mutant, we disrupted all
three H2-hydrogenases (14028
hyd3; Materials and Methods). For
studying gut colonization in the face of an intact microbiota, we
employed the LCM model. LCM mice are ex-germfree C57BL/6
mice which had been colonized by the 8 strains of the altered
Schädler flora and which had incorporated several dozen of
additional strains into their microbiota during subsequent housing
[8,9]. Importantly, the microbiota of LCM mice features most
characteristics of a typical complex microbiota, including phylum-
level composition, microbiota cell density and the ability to
generate a steady state level of about 50 mM H2 in the cecum
lumen [7–9,14]. Importantly, these mice do feature an attenuated
colonization resistance. This is quite different from mice with a
complex, specified pathogen-free (SPF) microbiota (further termed
SPF), which allow only low-level gut colonization by Salmonella
spp. in most mice (approx. 102–106 cfu/g in 95% of the animals
tested; [9,41,42]. Thus, efficient and reproducible gut colonization
of SPF mice by S. Typhimurium is only achieved upon antibiotic
treatment which transiently disrupts the microbiota and alleviates
colonization resistance [41,43–50]. In LCM mice, S. Typhimur-
ium SL1344 can grow up in the gut lumen and reaches
colonization densities of 108 cfu/g by day 1 p.i., reaches 109
cfu/g by day 3 and gut inflammation is triggered around day 3 p.i.
[8]. Therefore, the LCM mice allow studying how S. Typhimur-
ium establishes gut luminal colonization in the face of an intact
microbiota.
LCM-mice were infected with a 1:1 mixture of wild type
ATCC14028 (14028WT) and 14028hyd3 via the oral route (56107
cfu in total, by gavage). We analyzed the bacterial loads in the
feces at days 1–4 p.i. (Fig. 1A, B), monitored pathogen loads in
the cecum lumen, the mesenteric lymph nodes, the spleens and
the livers, and analyzed the mucosal inflammation at day 4 p.i.
(Fig. 2A–C). In the feces of the LCM-mice, 14028hyd3 featured a
pronounced colonization defect already by day 1 p.i. (competitive
index C.I. 0.02; Fig. 1A, B). During the subsequent three days,
the total fecal pathogen loads rose from <108 cfu/g to about 109
cfu/g while the C.I. did not drop any further. Control infections
were performed in streptomycin pretreated conventional mice
(56107 cfu in total, by gavage; 1 day infection). In these animals,
the microbiota is transiently disrupted by streptomycin and
14028hyd3 does not feature any gut luminal colonization defect
(Fig. 1A, B). These data are strikingly similar to our earlier data
obtained with H2-hydrogenase mutants of SL1344 [8] and
indicated that ATCC14028 can subvert H2 for gut luminal
colonization.
In the cecum lumen, 14028hyd3 had a similar colonization defect
as in the feces (Fig. 2A, B) and all mice featured pronounced
mucosal inflammation by day 4 p.i. (Fig. 2C). Furthermore, we
Microbiota H2 fuels S. Typhimurium 14028 Growth in Gut
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detected a significant colonization defect of 14028hyd3 in the mLN,
the spleens and the livers of the LCM mice (Fig. 2A, B). However
the attenuation appeared to be slightly less pronounced than in the
cecum lumen and in the feces. However, these data could not
unequivocally settle whether H2-hydrogenase dependent growth
might contribute to some extent to systemic colonization.
H2-hydrogenases do not contribute to systemic growth
of ATCC14028
In a second approach, we specifically addressed whether H2-
hydrogenases contribute to systemic colonization. To this end, we
infected LCM-mice via the intravenous route with a 1:1 mixture
of 14028WT and 14028hyd3 (56103 cfu in total, i.v.). After three
days, the animals were sacrificed and we analyzed the pathogen
loads (and the C.I.) in the cecum lumen, the mLN, the spleens
and the livers and assessed gut inflammation in the cecum tissue
(Fig. 3A–C). The total pathogen loads in the mLN (<104–105
cfu), the spleens (<107 cfu) and the livers (<107 cfu) were well in
line with published data for i.v. infections in C57BL/6 mice [51].
Strikingly, 14028hyd3 did not feature any detectable colonization
defect in the systemic organs after i.v. infection (p$0.05; C.I.<1;
Fig. 3A). Colonization defects of 14028hyd3 were only detected in
the cecum lumen in 5 out of 7 mice. This population must have
arisen by pathogen dissemination from systemic sites to the gut
lumen, e.g. by pathogen routing via the gall bladder, by
phagocyte-mediated transport to the gut tissue [52–55] or by
oral ingestion by licking the injection site at the tail. In any case,
our data suggest that the growth defect of 14028hyd3 has most
likely arisen after the pathogen had arrived in the gut lumen.
These data established that ATCC14028 does not require H2-
hydrogenases for growth at systemic sites if the gut is bypassed
during the infection procedure. In the typhoid fever model [14] or
oral infections of LCM mice, gut luminal growth of the bacteria
seems to precede the spread to systemic sites. This gut luminal
growth most likely explains why H2-hydrogenase mutants are
found in lower numbers in the mLN, livers and spleens of the
animals than the isogenic wild type strain.
Figure 1. 14028hyd3 is impaired in early gut ecosystem
invasion. Gut colonization was monitored in two different mouse
models: streptomycin-pretreated conventional mice (sm-SPF) and low
complexity microbiota (LCM) mice. Mice were infected with a 1:1
mixture (56107 cfu by gavage) of 14028hyd3 and the isogenic
background strain (14028WT). Fecal loads of both strains were
determined by selective plating. (A) Competitive infection indices were
determined over 4 days. Ns = not significant (P$0.05), ** P,0.01,
Mann-Whitney U test. (B) Bacterial loads of both competing strains
(14028WT and 14028hyd3) are depicted Ns = not significant (P$0.05), *
P,0.05; one-tailed Wilcoxon matched pairs signed rank test on paired
data (dashed lines).
doi:10.1371/journal.pone.0110187.g001
Figure 2. Oral infection experiments revealed that in
ATCC14028, hydrogenases fuel pathogen growth in the
intestine. (A) LCM mice from Figure 1 were sacrificed at day 4 post
infection and competitive indices in the cecum and at systemic sites
were determined. ** P,0.01, Mann-Whitney U test. (B) Bacterial loads in
the cecum and at systemic sites of both competing strains are plotted.
Ns = not significant (P$0.05), * P,0.05; one-tailed Wilcoxon matched
pairs signed rank test on paired data (dashed lines). (C) Cecal tissue
sections were HE-stained and scored for intestinal inflammation.
doi:10.1371/journal.pone.0110187.g002
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It should be noted that the 14028hyd3 mutant used in our study
lacked all the three uptake-type H2-hydrogenases. Thus, formally
we cannot rule out that the requirement of a single hydrogenase is
masked by the absence of the other two hydrogenases. For
example, deletion of one hydrogenase might increase S. Tm
fitness, while deletion of another hydrogenase might decrease S.
Tm fitness. By analyzing both deletions in combination, the two
opposed effects will be compensated. However, this seems unlikely,
as none of the H2-hydrogenase mutants of SL1344 or
ATCC14028 that have been analyzed in the past had featured
higher virulence than the isogenic wild type strain [8,14].
Nevertheless, mutants lacking just one of the H2-hydrogenases at
a time would have to be studied in detail to address this in a
systematic fashion. In addition, differential expression of the three
H2-hydrogenases [15,17], strain-specific differences in the expres-
sion patterns and microbiota/environment-specific cues (e.g.
different H2 availability) might play a role. Indeed, the three
different hydrogenases have different hydrogenase activities [16].
Moreover, in typhoid fever model infections of SPF mice,
ATCC14028 may utilize several different H2-hydrogenases [14].
In contrast, SL1344 growth in the gut lumen of LCM mice relied
exclusively on hyb, not the other H2-hydrogenases [8]. The
environmental cues steering the differential hydrogenase expres-
sion in vivo remain to be established. Nevertheless, it seems quite
safe to assume that the gut lumen is the site where H2-utilization
by S. Typhimurium is most prominent. Still, H2 could represent
an auxiliary reductant for Salmonella at systemic sites under
otherwise poor nutrient conditions, or when the microbiota is
especially active in fermentative metabolism (e. g. high H2
production).
In conclusion, our data establish that ATCC14028 is strikingly
similar to SL1344 in requiring H2-hydrogenases for growth in the
gut, not at systemic sites. This may suggest that the use of H2 for




All strains used in this study are derivates of the Salmonella
enterica serovar Typhimurium ATCC14028 (IR715), in which a
streptomycin resistance was added by P22 phage transduction of
the aadA gene from S. Tm SL1344 [35]. Deletions in the
hydrogenase genes were constructed by lambda/red homologous
recombination [56] as described previously [8] (Table 1).
Mouse infection experiments
All mice used in this study are C57BL/6 background and bred
at the Rodent Center HCI (RCHCI) (ETH Zurich, Switzerland).
Low complex microbiota (LCM) mice are ex-germfree mice which
were colonized with the Altered Schaedler flora-cocktail in 2007
[9] and ever since bred under strict hygienic isolation. Co-infection
experiments were performed as described previously [41] in 8 to
10 week old mice. Pre-treatment with 20 mg streptomycin was
only performed if indicated (Figure 1). For infection, both bacterial
strain (14028WT to 14028hyd3) were grown for 12 h in 0.3 M NaCl
supplemented LB medium, diluted 1:20 and sub-cultured for 4 h
in the same medium and mixed in a 1:1 ratio. For oral infections,
mice were infected with 5?107 cfu bacteria by gavage. For
intravenous infections, 5?103 cfu bacteria were injected into the tail
vein. Mice were sacrificed on day 1 p.i., day 3 p.i or day 4 p.i. by
cervical dislocation. Freshly collected fecal pellets, cecum content
and organs were homogenized in PBS (0.5% tergitol, 0.5% bovine
serum albumin). Differential plating on MacConkey agar (Oxoid)
supplemented with the appropriate antibiotics (50 mg/mL strep-
tomycin, 50 mg/mL kanamycin and 30 mg/mL chloramphenicol)
was performed to determine bacterial population sizes. The
competitive index was calculated by division of the population size
of 14028hyd3 by the population size of 14028WT. This ratio as
corrected for the ratio of both strains in the inoculum. Parts of the
cecal tissue were embedded in OCT (Sakura), cryosections were
prepared and stained with hematoxiline/eosine. HE-stained
sections were evaluated by scoring for submucosal edema, PMN
Figure 3. Intravenous infection experiments verified that in
ATCC14028, hydrogenases are not required for growth at
systemic sites. (A) LCM mice were intravenously infected with a 1:1
mixture of the 14028hyd3 and the isogenic background strain (14028WT)
(56103 cfu). Animals were sacrificed at day 3 p.i. and competitive
indices in the cecum and at systemic sites were determined. Ns = not
significant (P$0.05), Mann-Whitney U test. (B) Bacterial loads in the
cecum and at systemic sites of both competing strains are plotted. Ns
= not significant (P$0.05); one-tailed Wilcoxon matched pairs signed
rank test on paired data (dashed lines). (C) Cecal tissue sections were
HE-stained and scored for intestinal inflammation.
doi:10.1371/journal.pone.0110187.g003
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infiltration, presence of goblet cells and epithelial damage with a
maximum score of 13 [57].
Statistical analysis
The one-sided Wilcoxon matched-pairs signed rank test and the
exact Mann-Whitney U test were performed using the software
Graphpad Prism Version 6.0 for Windows (GraphPad Software,
La Jolla California USA, www.graphpad.com). P values of less
than 0.05 were considered as statistically significant. To compare
C.I.s to C.I. of inoculi, ratios of 14028hyd3 and 14028WT were
compared to the ratio of both strains in the inoculum using an
exact Mann-Whitney U test.
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